Which VCs invest in health wearables?

This blog post has been written by the person who has mapped the health wearables market in a clean and beautiful presentation

Health wearables represent one of the most dynamic sectors in venture capital, with $2.5 billion invested in 2024 alone and an additional $2.9 billion flowing into medtech and digital health in Q1 2025.

The sector attracts both specialized healthcare VCs and generalist funds, with investors particularly focused on AI-driven continuous monitoring, non-invasive glucose sensing, and integration with telehealth platforms. Major corporates like Apple, Google, and Samsung are increasingly acquiring startups or forming strategic partnerships to enhance their ecosystem offerings.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

Who are the top VCs actively investing in health wearables right now, and what companies have they recently backed?

The health wearables investment landscape is dominated by a mix of specialized healthcare funds and generalist VCs with strong track records in deep tech and consumer health.

How much funding have health wearable startups raised in total in 2024 and so far in 2025?

Health wearable startups secured approximately $2.5 billion in dedicated funding throughout 2024, representing a robust investment climate despite broader market headwinds.

The first quarter of 2025 has already seen $2.9 billion flow into the broader medtech, digital health, and wearables category across 63 funding rounds. This represents a strong start to the year, with late-stage rounds (Series D+) commanding a median size of $105 million.

The funding distribution shows healthy activity across all stages, with Series A rounds representing the largest segment at 35% of deals, followed by seed/pre-seed at 30%. Growth-stage funding (Series C+) accounts for 17% of deals but represents disproportionately larger dollar amounts due to mega-rounds from established players like Whoop and Oura.

European markets have shown particularly strong momentum with 36% year-over-year growth in Q1 2025, driven by increased interest in advanced biosensor technologies and regulatory clarity around medical device approval pathways.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

Which specific technologies or R&D breakthroughs in health wearables are VCs currently financing?

Venture capital is flowing heavily into four core technology areas that represent the next generation of health wearables beyond basic fitness tracking.

AI-enhanced continuous monitoring represents the largest investment category, with VCs backing startups developing predictive anomaly detection systems and personalization engines. These technologies enable wearables to move from reactive data collection to proactive health insights, with companies like Biolinq raising $138.3 million for their predictive glucose monitoring platform.

Non-invasive biochemical sensing using advanced photonics is attracting significant capital, particularly for glucose monitoring without finger pricks. This technology addresses a $15+ billion diabetes management market, with investors betting on startups that can achieve clinical-grade accuracy through optical sensors and machine learning algorithms.

High-resolution biosensors for ECG/EEG monitoring are receiving substantial funding for applications beyond fitness, including arrhythmia detection, stress monitoring, and neurological disorder management. Empatica's $41.7 million funding round exemplifies this trend, as their FDA-cleared wearables target epilepsy detection and management.

Smart textiles and IoT-integrated patches represent an emerging category where VCs are making early bets on seamless integration into daily life. These technologies promise continuous monitoring without traditional wearable form factors, with Johnson & Johnson Ventures actively backing patch-based monitoring solutions for post-surgical care and chronic disease management.

What size of investment rounds are VCs typically participating in for health wearables, and at what stage?

Health wearables funding follows a predictable progression from seed through growth stages, with round sizes reflecting the capital-intensive nature of hardware development and regulatory approval processes.

The median late-stage round (Series D+) has reached $105 million, reflecting the substantial capital requirements for scaling manufacturing, achieving regulatory compliance across multiple markets, and building consumer brand recognition in a competitive landscape.

VCs are increasingly willing to write larger checks at earlier stages for startups with breakthrough technology or experienced founding teams, particularly when the technology addresses large addressable markets like diabetes management or cardiovascular monitoring.

What geographical markets are most VCs focused on when it comes to health wearable investments?

North America dominates health wearables VC activity, capturing approximately 60% of all deals and housing 70% of wearables unicorns, driven by favorable regulatory frameworks and established healthcare infrastructure.

The United States leads with major hubs in Silicon Valley, Boston, and New York, where proximity to both technology talent and healthcare systems creates ideal conditions for wearables innovation. Key advantages include FDA regulatory clarity, established relationships between VCs and healthcare providers, and a consumer market willing to adopt premium health technologies.

Europe represents the fastest-growing region with 36% year-over-year funding growth in Q1 2025, led by the United Kingdom, Germany, and Nordic countries. European startups benefit from strong engineering talent, progressive healthcare systems willing to integrate digital health solutions, and GDPR-compliant data handling that builds consumer trust.

Asia-Pacific is emerging as a significant player, particularly in Singapore, India, and China, with focus areas including non-invasive sensor development and manufacturing cost optimization. Singapore serves as a regional hub due to government support for medtech innovation, while India and China offer large-scale manufacturing capabilities and massive addressable markets for cost-effective health monitoring solutions.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

Which major corporations are directly or indirectly investing in or acquiring health wearable startups?

Technology giants and healthcare corporations are aggressively pursuing health wearables through both direct investment and strategic acquisitions to build comprehensive health ecosystems.

Apple continues expanding its HealthKit ecosystem through both internal development and strategic partnerships, with the company's Health Innovation Fund making targeted investments in startups that complement Apple Watch capabilities. Their focus areas include mental health monitoring, women's health tracking, and integration with electronic health records.

Google, following its $2.1 billion Fitbit acquisition in 2021, maintains active partnerships with startups like Oura to enhance Google Health's data integration capabilities. The company's investment strategy focuses on AI-driven health insights and integration with Google Cloud's healthcare data platforms.

Samsung Ventures actively invests in advanced biosensor technologies and smart textile innovations that could enhance Galaxy Watch functionality. Their portfolio includes partnerships for blood pressure monitoring, body composition analysis, and sleep optimization technologies.

Healthcare giants pursue different angles: Johnson & Johnson Innovation backs wearable patch manufacturers for post-surgical monitoring and medication adherence, while Philips Health Capital invests in telemonitoring wearables that integrate with hospital systems. Medtronic focuses on acquisitions that enhance their diabetes and cardiac care portfolios, particularly continuous monitoring technologies that complement their existing device ecosystems.

If you want to build or invest on this market, you can download our latest market pitch deck here

What are the most notable startup success stories in this space recently, and who funded them?

The health wearables sector has produced several standout success stories that demonstrate the market's maturation and the strategic value these companies bring to both VCs and potential acquirers.

These success stories demonstrate different viable paths to scale: Whoop and Oura focus on premium consumer markets with subscription models, Empatica targets medical applications with FDA approval, and Biolinq pursues breakthrough technology for massive addressable markets.

What conditions or terms do VCs generally require in health wearable deals?

Health wearables deals typically involve more complex terms than pure software investments due to hardware development risks, regulatory requirements, and longer time-to-market cycles.

Equity stakes range from 10-20% for Series A rounds to 5-10% for growth-stage investments, with VCs often requiring anti-dilution protection and liquidation preferences given the capital-intensive nature of hardware development. Lead investors typically secure one board seat, while strategic investors may negotiate observer rights to stay informed about product development and regulatory progress.

Pro-rata and follow-on rights are standard from seed stage through growth rounds, as successful wearables companies often require multiple funding rounds to reach commercial scale. VCs particularly value these rights given the potential for significant value creation between regulatory approval milestones and commercial launch.

Protective provisions become more sophisticated in later rounds, often including approval rights for key decisions such as regulatory strategy changes, major partnership agreements, and IP licensing deals. These provisions reflect the strategic importance of regulatory pathways and partnership relationships in determining commercial success.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

Which VCs have shown a consistent track record in health tech and wearable innovation over the past few years?

Several venture capital firms have established themselves as consistent players in health wearables through repeated investments, successful exits, and deep sector expertise built over multiple funding cycles.

SOSV through their HAX hardware accelerator has incubated over 1,000 startups and maintains the most active early-stage presence in wearables, with multiple successful exits including Empatica and other device-focused companies. Their hardware expertise and manufacturing connections in Asia provide unique value beyond capital.

OrbiMed has demonstrated consistent success in deep-science medtech investments with exits including Insulet and Dexcom, positioning them as a preferred partner for startups pursuing FDA-regulated medical wearables. Their healthcare expertise and regulatory navigation capabilities make them particularly valuable for companies targeting clinical applications.

Rock Health has operated as a digital health pioneer since 2010 with over 200 portfolio company exits, establishing relationships across the entire healthcare ecosystem from payers to providers. Their specialized focus and extensive network provide strategic value for wearables companies seeking healthcare system integration.

Oak HC/FT and Bessemer Venture Partners have built substantial portfolios across multiple health tech categories, providing both capital and strategic guidance for scaling from prototype to commercial success. Their multi-stage presence allows them to support companies through the entire development lifecycle, from early R&D through IPO preparation.

If you need to-the-point data on this market, you can download our latest market pitch deck here

What are the strategic goals behind these VC investments—are they looking for exits, integrations, or long-term bets?

VC strategic objectives in health wearables divide into three primary categories, with most investors pursuing a portfolio approach across multiple exit strategies.

Approximately 40% of investments target strategic acquisitions by established players like Apple, Medtronic, or Google, where startups provide technology or talent acquisition opportunities. These deals typically occur at the Series B-C stage when technology validation is complete but before full commercial scale, allowing acquirers to integrate innovations into existing product lines.

Platform integration strategies account for 35% of VC objectives, focusing on companies that can embed their technology into broader digital health ecosystems rather than standalone consumer products. These investments often target B2B2C models where wearables integrate with telehealth platforms, electronic health records, or employer wellness programs.

Long-term independent growth represents 25% of VC strategies, typically focused on companies with strong intellectual property portfolios and defensible market positions. These investments target IPO exits or become substantial independent companies that can compete directly with established players through breakthrough technology or superior user experience.

The strategic approach often depends on the startup's technology readiness, market positioning, and founding team background, with VCs adjusting their support and guidance accordingly to optimize for the most likely successful outcome.

How much growth is forecasted for the health wearables market in 2026, and how does that influence VC activity now?

The wearable fitness technology market is projected to grow from $15.06 billion in 2025 to $16.57 billion in 2026, representing a solid 10% compound annual growth rate that continues to attract substantial venture capital investment.

This growth forecast influences current VC activity by creating urgency around market positioning, as investors recognize that companies achieving scale now will benefit disproportionately from market expansion. The relatively modest but consistent growth rate suggests a maturing market where competitive advantages become increasingly important.

VCs are particularly focused on companies that can capture market share through technological differentiation rather than relying solely on overall market growth. This has led to increased investment in breakthrough technologies like non-invasive glucose monitoring and AI-driven health insights that can command premium pricing and build sustainable competitive moats.

The forecast also drives strategic timing decisions, with VCs encouraging portfolio companies to achieve key milestones before 2026 when increased competition and market maturity may make differentiation more challenging. This creates pressure for rapid scaling and aggressive go-to-market strategies, influencing both funding strategies and operational execution.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

What signals suggest a health wearable startup is fundable in this market—team, patents, traction, medical validation, partnerships?

Health wearable startups that successfully attract VC funding demonstrate specific combinations of team expertise, intellectual property protection, market validation, and strategic partnerships that reduce investment risk and increase exit potential.

Founding teams with clinical experience combined with engineering expertise represent the strongest fundability signal, as VCs recognize that successful health wearables require both technical innovation and deep understanding of healthcare workflows. Teams that include former employees from companies like Apple Health, Fitbit, or established medical device manufacturers bring credible industry connections and regulatory experience.

Patent portfolios and clear regulatory pathways provide essential defensibility and market access, with VCs particularly valuing startups that have begun FDA or CE mark processes early in development. Strong IP positions in core sensing technologies or data analysis algorithms create barriers to entry that protect market share and enable premium pricing.

Clinical validation through peer-reviewed studies or pilot deployments with healthcare providers demonstrates real-world efficacy beyond laboratory testing. VCs increasingly require evidence that wearables provide actionable health insights rather than just data collection, particularly for applications targeting medical rather than fitness markets.

Strategic partnerships with healthcare systems, device OEMs, or technology platforms signal market validation and provide distribution channels that reduce customer acquisition costs. These relationships often determine commercial success and are heavily weighted in funding decisions, particularly for B2B2C business models targeting healthcare system integration.

Conclusion

Sources

1. LinkedIn - Ultrahuman Wearable Tech Report
2. DealForma - Q1 2025 Medtech and Wearables M&A Report
3. OpenVC - Wearables Investors List
4. Seedtable - Wearables Investors
5. LinkedIn - Sophie Harris Health Innovation Post
6. Accretive Edge - Digital Health Investors 2025
7. Seedtable - Best Wearables Startups
8. GreyB - Wearable Health Monitoring Startups
9. All Health Tech - Q1 2025 Rock Health Report
10. HIT Consultant - US Digital Health Funding Q1 2025
11. Future Market Insights - Wearable Fitness Technology Market
12. Papermark - Health Tech Investors
13. Kepler - Top 10 HealthTech VC Funds
14. Dealroom - Top VC Investors in HealthTech
15. Exploding Topics - Wearable Startups
16. HealthTech50
17. SeedBlink - Europe's HealthTech Investment Landscape 2025
18. HolonIQ - HealthTech Unicorns
19. Vestbee - Top Health Tech VC Funds in Europe
20. TopTier Impact - HealthTech MedTech BioTech VCs
21. Galen Growth - Q1 2025 Digital Health Funding Trends
22. Life Science Market Research - Q1 2025 Medical Device Investment
23. MDDIOnline - MedTech Wearables Investor Perspective